Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Diluent capable of improving stability of acridinium ester antigen-antibody conjugate and reducing background and preparation method thereof

A technology of antigen-antibody and conjugates, which is applied in the field of immunoassay, can solve the problems of reagent performance and stability discount, non-specific binding increase, diluent effect is not good, etc., to achieve good protection effect, less components, and good blocking Sexual and protective effects

Pending Publication Date: 2020-10-30
山东康华生物医疗科技股份有限公司
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, in the specific implementation process, the acridinium ester antigen-antibody conjugate is not as stable as imagined. It is easy to be hydrolyzed in the general buffer solution, and the reagent is prone to instability. During the long-term storage process, the background is usually easy to increase. , due to the poor effect of preserving the diluent, long-term storage, the protection is reduced, so the non-specific binding is increased, which will greatly reduce the performance and stability of the reagent

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diluent capable of improving stability of acridinium ester antigen-antibody conjugate and reducing background and preparation method thereof
  • Diluent capable of improving stability of acridinium ester antigen-antibody conjugate and reducing background and preparation method thereof
  • Diluent capable of improving stability of acridinium ester antigen-antibody conjugate and reducing background and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0059] Embodiment 1: A diluent that can improve the stability of the acridinium ester antigen-antibody conjugate and reduce the background, including the following components:

[0060] Tris-base: 5.0g;

[0061] Concentrated hydrochloric acid: 3.5mL;

[0062] Polyethylene glycol-6000: 9.0g;

[0063] 10% sodium lauryl sulfate: 0.95mL;

[0064] Tween: 9.5mL;

[0065] Disodium edetate: 0.8g;

[0066] Sodium casein: 9.0g;

[0067] Proclin300: 0.95mL;

[0068] Triton X-100: 9.5mL;

[0069] Use purified water for in vitro diagnostic reagents, add to 1000mL.

[0070] A method for preparing a diluent capable of improving the stability of an acridinium ester antigen-antibody conjugate and reducing the background, comprising the following steps:

[0071] In the first step, according to the above formula, each component is weighed for subsequent use;

[0072] In the second step, take an appropriate amount of purified water, add Tris-base, polyethylene glycol 6000, 10% sodium laur...

Embodiment 2

[0077] A diluent capable of improving the stability of an acridinium ester antigen-antibody conjugate and reducing the background, comprising the following components:

[0078] Tris-base: 6.057g

[0079] Concentrated hydrochloric acid: 3.8mL

[0080] Polyethylene glycol-6000: 10g

[0081] 10% sodium lauryl sulfate: 1.0mL

[0082] Tween: 10mL

[0083] Disodium EDTA: 0.93g

[0084] Sodium casein: 10g

[0085] Proclin300: 1.0mL

[0086] Triton X-100: 10mL

[0087] Purified water, add to 1000mL.

[0088] A method for preparing a diluent capable of improving the stability of an acridinium ester antigen-antibody conjugate and reducing the background, comprising the following steps:

[0089] In the first step, according to the above formula, each component is weighed for subsequent use;

[0090] In the second step, take an appropriate amount of purified water, add Tris-base, polyethylene glycol 6000, 10% sodium lauryl sulfate, Tween, disodium edetate, Proclin300, and Triton X-...

Embodiment 3

[0095] A diluent capable of improving the stability of an acridinium ester antigen-antibody conjugate and reducing the background, comprising the following components:

[0096] Tris-base: 7.0g

[0097] Concentrated hydrochloric acid: 4.0mL

[0098] Polyethylene glycol-6000: 11.0g

[0099] 10% sodium lauryl sulfate: 1.05mL

[0100] Tween: 10.5mL

[0101] Disodium EDTA: 1.0g

[0102] Sodium casein: 11.0g

[0103] Proclin300: 1.05mL

[0104] Triton X-100: 10.5mL

[0105] Use purified water for in vitro diagnostic reagents, add to 1000mL.

[0106] A method for preparing a diluent capable of improving the stability of an acridinium ester antigen-antibody conjugate and reducing the background, comprising the following steps:

[0107] In the first step, according to the above formula, each component is weighed for subsequent use;

[0108] In the second step, take an appropriate amount of purified water, add Tris-base, polyethylene glycol 6000, 10% sodium lauryl sulfate, Twee...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a diluent capable of improving the stability of an acridinium ester antigen-antibody conjugate and reducing the background. The diluent comprises the components of 5 to 7g of Tris-base, 3.5 to 4.0 mL of concentrated hydrochloric acid, 9 to 11 g of polyethylene glycol-6000, 0.95 mL to 1.05 mL of 10% lauryl sodium sulfate, 9.5 mL to 10.5 mL of Tween, 0.8 to 1.0 g of ethylene diamine tetraacetic acid disodium salt, 9 to 11 g of sodium caseinate, 0.95 mL to 1.05 mL of Proclin 300, 9.5 to 10.5 mL of triton X-100, and 1000mL of purified water for an in-vitro diagnostic reagent. The diluent has the advantages that the components are few; polyethylene glycol 6000, sodium dodecyl sulfate, tween and several active agents are mixed for use, meanwhile, a Tris-base buffer solution system is used, and multiple raw materials play a mutual synergistic effect, so that the diluent has a better protection effect on acridinium ester labeled antigens and antibodies, can be stored for a long time, can provide good blocking property and protectiveness for the antibodies, and reduces non-specific reactions; meanwhile, the material cost is saved, the specificity, stability, repeatability and other properties of the reagent are not influenced, and the reagent is suitable for popularization and application.

Description

technical field [0001] The invention relates to the technical field of immunoassay. [0002] Specifically, it relates to a diluent capable of improving the stability of an acridinium ester antigen-antibody conjugate and reducing background and a preparation method thereof. Background technique [0003] Acridine salts and related compounds have proven to be very advantageous chemiluminescent labels, with stability, activity and sensitivity exceeding those of radioactive isotopes. Acridine esters can react with any protein containing amino groups. Under alkaline conditions, NHS will leave, and acridinium esters will bind to proteins with a stable amide bond to form acridine compounds. After the reaction is complete, excess acridinium salts are removed through a desalting column. [0004] In the presence of alkaline hydrogen peroxide, acridine-labeled proteins can emit light without enzymatic catalysis. After adding the excitation reagent, the system releases photons immedia...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/531
CPCG01N33/531
Inventor 杨帆曲林琳许建成刘云田永帅杨锋斌
Owner 山东康华生物医疗科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products